Abstract
With the conclusive evidence from randomized controlled trials of the efficacy of mammographic screening in reducing mortality from breast cancer, the emphasis for the public health community has shifted to evaluation of service screening programs. Here, we briefly review the major approaches available for mortality-based evaluation of breast cancer screening programs and identify some design and analytic issues arising from these methodologic approaches. If care is taken to avoid or correct for biases, reliable evaluation of the mortality effect of service screening is possible. Results suggest that service screening programs are achieving breast cancer mortality reductions at least as great, and sometimes greater, as those observed in the trials.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
